The organizations include:
• LUNGevity Foundation
• Metastatic Breast Cancer Alliance
• Multiple Myeloma Research Foundation
• Pancreatic Cancer Action Network
• Prostate Cancer Foundation
The accelerator is focused on developing a business framework to share solutions that help advance precision medicine. It will work to enhance four elements of precision medicine: direct to patient; data and analytics; clinical trials; and venture and investment.
It is currently testing the “Right Track,” a framework that connects cancer patients with patient-focused organizations to enable them to optimize their treatment journey. The framework was developed using market research that pinpointed gaps in knowledge and actions among patients with five types of cancer.
More articles on precision medicine:
Study predicts patients’ disease risks using emergency contacts
Intermountain expands precision genomics DNA test to all providers
UCSF Health, UChicago Medicine partner with Color to offer patients genetic tests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
